SAO PAULO (Reuters) – Shareholders of Brazilian healthcare operator Hapvida approved a change to the company’s bylaws that will force any shareholder or group of shareholders with a stake larger than 20% to launch a tender offer for all remaining shares.
The mechanism, known as a “poison pill,” was approved by a majority of Hapvida shareholders in a general meeting on Tuesday, according to the meeting minutes.
(Reporting by Andre Romani; Editing by Leslie Adler)
Comments